TKNO vs TLRY

Alpha Teknova, Inc. vs Tilray Brands, Inc. — Valuation Comparison 2026

By CirclFi Research Team · Updated 2026-06-03 · Data from SEC EDGAR, FRED & GDELT

Quick Summary — TLRY scores higher on quality with 6.8/10 vs TKNO's 5.3/10. TKNO trades at $5.18 while TLRY trades at $5.38. Both analyzed daily using SEC EDGAR data across 13 institutional models.

TKNO

Drug Manufacturers - Specialty & Generic
Alpha Teknova, Inc.
Quality
5.3
out of 10
Value Trap
18
SAFE
Price
$5.18
Last close
Models
11/13
Active
VS

TLRY

Drug Manufacturers - Specialty & Generic
Tilray Brands, Inc.
Quality
6.8
out of 10
Value Trap
45
WARN
Price
$5.38
Last close
Models
10/13
Active
TKNO
2 models active
Limited to 2/13 visible models
TLRY
Dynamic NAV sees +32.1% upside
Value Trap 45/100 — caution

TKNO vs TLRY — Fair Value Comparison

TKNO
$0$2$4$6 Price$5.18 Bayesian …$1.20 (-76.9%) Earnings …$1.50 (-56.0%)
TLRY
$0$3$6$8 Price$5.38 Bayesian …$1.53 (-71.5%) Dynamic N…$7.11 (+32.1%)
Market Price Model 1 Model 2

Model-by-Model Comparison

ModelType TKNO Fair ValueTKNO Upside TLRY Fair ValueTLRY Upside
Bayesian DCF Intrinsic $1.20 -76.9% $1.53 -71.5%
Earnings Power Value Intrinsic $1.50 -56.0% — —
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.62 -88.0% $7.11 +32.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%

TKNO vs TLRY — Which Stock Is More Undervalued in 2026?

TLRY scores higher with a 6.8/10 quality rating vs TKNO's 5.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do TKNO and TLRY Valuations Compare?

At $5.18, TKNO trades +76.9% above its Bayesian DCF fair value of $1.20, while TLRY at $5.38 trades +71.5% above its estimate of $1.53. TKNO shows a wider gap between price and intrinsic value.

Quality of Company: TKNO vs TLRY

TKNO earns a Quality of Company score of 5.3/10 compared to TLRY's 6.8/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: TKNO vs TLRY

TKNO carries a SAFE value trap risk (18/100) while TLRY shows WARN risk (45/100). Stocks with value trap scores above 40 may appear undervalued but face deteriorating fundamentals — declining margins, rising debt, or shrinking revenue can make the apparent discount a trap.

Both in Drug Manufacturers - Specialty & Generic

Both TKNO and TLRY operate in Drug Manufacturers - Specialty & Generic, which has 79 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare TKNO vs TLRY differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo  ·  FactSet: ~$1,000/mo  ·  CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

TKNO
View Full Alpha Teknova, Inc. Analysis →
TLRY
View Full Tilray Brands, Inc. Analysis →
See all Drug Manufacturers - Specialty & Generic stocks →